SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 228, doi. 10.1002/1878-0261.12838
- By:
- Publication type:
- Article